- JP-listed companies
- TEIJIN LIMITED
- Cash flow
TEIJIN LIMITED (3401) Cash flow
Market cap
¥318.2B
P/E ratio
6.9x
Teijin develops and manufactures high-performance materials, fibers, and healthcare products including aramid fibers, pharmaceuticals, and medical devices.
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | - | - | - | - | - | - | - | - | - | 78,032 | 71,026 | 60,315 |
| Cash from operations | 76,030 | 80,640 | 79,040 | 80,091 | 80,899 | 94,214 | 107,729 | 89,656 | 55,086 | 69,451 | 69,843 | 98,654 |
| Capital expenditures | -26,527 | -31,895 | -37,662 | -42,604 | -55,599 | -66,301 | -56,817 | -60,593 | -51,512 | -58,112 | -57,397 | -53,514 |
| Cash from investing | -49,624 | -40,322 | -127,650 | -51,307 | -41,288 | -67,922 | -79,587 | -198,375 | -52,427 | -46,052 | 52,517 | -38,956 |
| Payments for dividends | -3,930 | -4,914 | -8,849 | -11,804 | -11,688 | -13,427 | -10,557 | -10,082 | -10,571 | -5,292 | - | - |
| Repurchases of common stock | - | - | - | -21 | -20,039 | -12 | -8 | -18 | -5 | -15 | -6 | -5 |
| Proceeds from issuance of term debt, net | 37,534 | 36,707 | 98,761 | 16,051 | 25,918 | 16,675 | 35,692 | 23,529 | 41,500 | 25,000 | 5,984 | - |
| Repayments of term debt | -25,805 | -21,820 | -27,309 | -45,831 | -27,858 | -6,735 | -37,835 | -16,439 | -37,150 | -62,936 | -48,543 | -65,915 |
| Cash from financing | 10,393 | -8,316 | 63,765 | -31,485 | -15,353 | -8,059 | -20,878 | 71,113 | 7,180 | -43,159 | -134,459 | -73,251 |